| CRISPR Medicine | This is an overview of all our articles
Some of the best links we picked up around the internet
Researchers have identified ARL11 as a critical factor in resistance to PARP inhibitor therapy through a genome-wide CRISPR activation screen,...
Durham-based Precision BioSciences has received IND clearance for PBGENE-HBV, making it the first investigational in vivo gene-editing therapy to...
A Spanish study explores a CRISPR-based gene therapy approach for Ewing sarcoma. The in vivo treatment reduced tumour growth in mice, with no...
Scientists used lipid nanoparticles to deliver CRISPR-Cas9 targeting Hao1 for the treatment of primary hyperoxaluria type 1. Proof-of-concept studies...
